Treosulfan Unknown Status Phase 2 Trials for Haematological Malignancies / Allogeneic Transplantation Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00129155MiniMUD Study - Unrelated Reduced Intensity Conditioning With TreosulfanĀ® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies